143
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Plakophilin-2 Promotes Lung Adenocarcinoma Development via Enhancing Focal Adhesion and Epithelial–Mesenchymal Transition

, ORCID Icon, , &
Pages 559-570 | Published online: 22 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hao Yan, Yong Zhou, Zhujiang Chen, Xiaokang Yan & Ling Zhu. (2022) Long non-coding RNA HCG11 enhances osteosarcoma phenotypes by sponging miR-1245b-5p that directly inhibits plakophilin 2. Bioengineered 13:1, pages 140-154.
Read now

Articles from other publishers (14)

Meng Dai, Yuantao Su & Zhixiong Wu. (2023) Downregulated expression of plakophilin‐2 gene in patients with colon adenocarcinoma predicts an unfavorable prognosis and immune infiltrate. The Journal of Gene Medicine 26:1.
Crossref
Aina Lluch, Jessica Latorre, Angela Serena-Maione, Isabel Espadas, Estefanía Caballano-Infantes, José M. Moreno-Navarrete, Núria Oliveras-Cañellas, Wifredo Ricart, María M. Malagón, Alejandro Martin-Montalvo, Walter Birchmeier, Witold Szymanski, Johannes Graumann, María Gómez-Serrano, Elena Sommariva, José M. Fernández-Real & Francisco J. Ortega. (2023) Impaired Plakophilin-2 in obesity breaks cell cycle dynamics to breed adipocyte senescence. Nature Communications 14:1.
Crossref
Erika Naakka, Wafa Wahbi, Riia Tiikkaja, Krista Juurikka, Toni Sandvik, Petri Koivunen, Timo Autio, Jukka Tikanto, Janne Väisänen, Hannu Tuominen, Anne Talvensaari-Mattila, Ahmed Al-Samadi, Rabah Soliymani, Pirjo Åström, Maija Risteli & Tuula Salo. (2023) Novel human lymph node-derived matrix supports the adhesion of metastatic oral carcinoma cells. BMC Cancer 23:1.
Crossref
Jianfeng Shu, Jinni Jiang & Guofang Zhao. (2023) Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis. Frontiers in Immunology 14.
Crossref
Yuqi Song, Jianzun Ma, Linan Fang, Mingbo Tang, Xinliang Gao, Dongshan Zhu & Wei Liu. (2023) Endoplasmic reticulum stress-related gene model predicts prognosis and guides therapies in lung adenocarcinoma. BMC Bioinformatics 24:1.
Crossref
Zhengsong Jiang, Xiang Wang, Jinghan Huang, Guoyin Li & Shangfu Li. (2023) Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma. Open Medicine 18:1.
Crossref
Guangyao Wang, Anqiao Wang, Li Wang, Guanglan Xu, Xiaohua Hong & Fang Fang. (2023) Identification and validation of novel lung adenocarcinoma subtypes and construction of prognostic models: based on cuprotosis-related genes. BMC Pulmonary Medicine 23:1.
Crossref
Fangchao  Zhao, Zengying Wang, Zhirong Li, Shiquan Liu & Shujun Li. (2022) Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma. Frontiers in Immunology 13.
Crossref
Wenhan Cai, Miao Jing, Jiaxin Wen, Hua Guo & Zhiqiang Xue. (2022) Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma. Frontiers in Genetics 13.
Crossref
Fushi Han, Dongdong Huang, Jinqian Meng, Jiapeng Chu, Meng Wang & Shuzhen Chen. (2022) miR‐126‐5p enhances radiosensitivity of lung adenocarcinoma cells by inhibiting EZH2 via the KLF2/BIRC axis. Journal of Cellular and Molecular Medicine 26:9, pages 2529-2542.
Crossref
Renping Wan, Hongliang Liao, Jingting Liu, Lin Zhou, Yingqiu Yin, Tianhao Mu & Jie Wei. (2022) Development of a 5-Gene Signature to Evaluate Lung Adenocarcinoma Prognosis Based on the Features of Cancer Stem Cells. BioMed Research International 2022, pages 1-28.
Crossref
Yanpin Ma & Huping Zhang. (2021) Genomics and Prognosis Analysis of N6-Methyladenosine Regulators in Lung Adenocarcinoma. Frontiers in Genetics 12.
Crossref
Lisa Müller, Mechthild Hatzfeld & René Keil. (2021) Desmosomes as Signaling Hubs in the Regulation of Cell Behavior. Frontiers in Cell and Developmental Biology 9.
Crossref
Ting-Ting Liu, Rui Li, Chen Huo, Jian-Ping Li, Jie Yao, Xiu-li Ji & Yi-Qing Qu. (2021) Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis. Frontiers in Cell and Developmental Biology 9.
Crossref